RFG Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$324K Buy
352
+5
+1% +$5.07K 0.08% 53
2025
Q4
$373K Buy
347
+4
+1% +$3.83K 0.09% 47
2025
Q3
$262K Buy
+343
New +$255K 0.07% 55
2024
Q4
Sell
-343
Closed -$304K 59
2024
Q3
$304K Buy
343
+19
+6% +$17.1K 0.11% 43
2024
Q2
$294K Buy
324
+25
+8% +$20K 0.11% 42
2024
Q1
$233K Buy
+299
New +$213K 0.1% 39

Other funds holding LLY

RFG Holdings's LLY Position: Q1 2026 in Review

RFG Holdings increased its Eli Lilly (LLY) stake by 1.4% in Q1 2026, buying an estimated $5.07K and bringing the position to 352 shares worth $324K. The position accounts for 0.08% of the portfolio, ranked #53.

RFG Holdings first reported a position in LLY in Q1 2024 and has held it in 6 quarters since. The position peaked at $373K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • RFG Holdings held 352 shares of Eli Lilly worth $324K as of Q1 2026.
  • RFG Holdings bought 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
  • Eli Lilly made up 0.08% of RFG Holdings's portfolio in Q1 2026, its #53 holding.
  • RFG Holdings first reported a position in Eli Lilly in Q1 2024 and has held it in 6 quarters since.
  • RFG Holdings's Eli Lilly position peaked at $373K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on RFG Holdings's 13F filing for Q1 2026, filed 16 Apr 2026.